HLB Life Science Co., Ltd. (KOSDAQ:067630)

HLB Life Science Revenue

HLB Life Science had revenue of 13.60B KRW in the quarter ending September 30, 2025, with 65.94% growth. This brings the company's revenue in the last twelve months to 114.33B, up 147.10% year-over-year. In the year 2024, HLB Life Science had annual revenue of 102.24B with 4.34% growth.

• Revenue (ttm): 114.33B
• Revenue Growth: +147.10%
• P/S Ratio: 4.07
• Revenue / Employee: 747.24M
• Employees: 153
• Market Cap: 465.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	102.24B	4.25B	4.34%
Dec 31, 2023	97.99B	-1.60B	-1.61%
Dec 31, 2022	99.59B	46.10B	86.17%
Dec 31, 2021	53.49B	-38.30B	-41.73%
Dec 31, 2020	91.80B	-22.22B	-19.49%